Thought Leadership
![Cancer white paper image](https://www.sciensus.com/wp-content/uploads/2024/01/White-paper-landing-page-image-640x233.png)
Thought Leadership, Rare diseases
Launching successful patient support programs for rare disease patients across Europe
![](https://www.sciensus.com/wp-content/uploads/2024/05/Comp-1-0-00-11-20-640x360.jpg)
Thought Leadership, Rare diseases
Market access for orphan drugs in Switzerland: a guide for Biotechs
![Role of ePROMs in cancer care](https://www.sciensus.com/wp-content/uploads/2024/04/Articles-for-website-templates-13-4-1-640x404.png)
Thought Leadership, Cancer
The benefits of digitally collecting PROMs to study patient wellbeing.
![](https://www.sciensus.com/wp-content/uploads/2024/03/Thought-leadership-strategies-for-entering-european-market-14-640x405.png)
Thought Leadership, Rare diseases
The impact of real-world data in gaining access to the European orphan drugs market.
![Patient wellbeing metrics - quality of life](https://www.sciensus.com/wp-content/uploads/2024/02/Articles-for-website-templates-13-3-1-640x404.png)
Thought Leadership, Long-term conditions
White Paper: Quality of Life
![cancer research white paper](https://www.sciensus.com/wp-content/uploads/2024/01/Articles-for-website-templates-13-640x404.png)
Thought Leadership, Cancer
White Paper: Investigating Patient Benefits in Home vs. Clinic-Based Treatment
![Real World Evidence in Cancer report image](https://www.sciensus.com/wp-content/uploads/2023/12/RWE-in-cancer-report-640x404.png)
Thought Leadership
The role of real-world evidence in reducing clinical uncertainty in cancer treatment.
![Navigating Expanded Access Programs in Europe](https://www.sciensus.com/wp-content/uploads/2023/12/MicrosoftTeams-image-34-640x720.jpg)
Thought Leadership, Rare diseases
Navigating expanded access in Europe: a strategic blueprint for biotech leaders
![Thought leadership - strategies for entering european market](https://www.sciensus.com/wp-content/uploads/2023/10/Thought-leadership-strategies-for-entering-european-market-640x404.jpg)
Thought Leadership, Rare diseases
Strategies for entering the European orphan drugs market